Novo Nordisk Shs Sponsored American DepositReceipt Repr 1 Sh -B- $46.05

down 0.00


31/7/2014 04:03 PM  |  NYSE : NVO  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get NVO Trend Analysis - it has underperformed the S&P 500 by 87%

Partner Headlines

  1. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  2. Jazz, Novo Among Medicals Showing Healthy Action

    IBD
  3. Biogen Hemophilia Drugs Launch Into The Unknown

    IBD
  4. Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  5. Novo, Other Medicals Display Healthy Action

    IBD
  6. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  7. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  8. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  9. Novo Nordisk lowers outlook

    IBD
  10. Transport, Drug Stocks Act Well Despite Market Woes

    IBD
  11. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  12. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  13. Stocks Rise In Higher Volume; Anika Jumps On Earnings

    IBD
  14. IBD 50: Auto, Other IBD 50 Stocks Forming Bases

    IBD
  15. Alexion, Biogen Among Leading Big-Cap Biotechs

    IBD
  16. Salix Among Stocks Getting Support At 10-Week Line

    IBD
  17. Assessing the New Boss at National Oilwell Varco

    GuruFocus
  18. Baxter Splitting In Effort To 'Unlock Trapped Value'

    IBD
  19. Drug, Airline Stocks Top Shortened Weekly Review

    IBD
  20. Baxter To Split Into Two Companies; Stock Jumps

    IBD
  21. Novo Nordisk Upgraded to 'Buy'

    FoxBusiness
  22. UPDATE: Novo Nordisk Reports Results from First Phase 3 Trial with N8-GP

    Benzinga
  23. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  24. Drugmakers Like Jazz, Shire Key To Europe's Recovery

    IBD
  25. European ETFs Flying Under The Radar

    Benzinga
  26. Pharmacyclics Hits High As Imbruvica Launches Big

    IBD
  27. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  28. Stocks Gain For Day, Week

    IBD
  29. Shire PLC: Time to Panic?

    GuruFocus
  30. AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is

    GuruFocus
  31. Bristol-Myers' Diabetes Sale Sharpens Biopharma Focus

    IBD
  32. AstraZeneca Buys Out Bristol-Myers' Diabetes Business

    IBD
  33. Benzinga's Volume Movers

    Benzinga
  34. Sanofi Continues to Struggle on Its Path to Recovery

    GuruFocus
  35. Lilly Pumps $700M into Insulin Manufacturing

    FoxBusiness
  36. Vertex Drug, Fastest Blockbuster, Quickly Fading

    YCharts
  37. Novo Nordisk Initiates European Share Buyback

    Benzinga
  38. Time To Consider Investing In Scandinavia (EWD, EFNL, NORW, EDEN, GXF)

    Benzinga
  39. Novo Nordisk Is Crying Foul In Liability Suit

    YCharts
  40. Novo Nordisk Pushes Ahead In Challenging Year

    IBD
  41. Benzinga's Top Downgrades

    Benzinga
  42. Top 4 Large-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  43. Pharma Stocks: Emerging Brainpower Shift

    YCharts
  44. Pharma’s China-Gate: So Much For Easy Growth

    YCharts
  45. Weekly Preview: Earnings Season Nears The End, China in Focus

    Benzinga
  46. Novo Nordisk (NVO) Drug Delay Draws Option Bears

    SchaeffersResearch
  47. Novo Plunges On FDA Action

    IBD
  48. Novo Nordisk Hit By Diabetes Drug Delay; Sanofi Rises

    IBD
  49. Stocks Little Changed; Ruger Briefly Dips Below Entry

    IBD
  50. Stocks Barely Dip; Starz Takes Off

    IBD
Trading Center